SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-141021
Filing Date
2011-05-16
Accepted
2011-05-16 13:12:31
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 380425
2 RESEACH & LICENSE AGREEMENT dex101.htm EX-10.1 324877
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex311.htm EX-31.1 6846
4 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex312.htm EX-31.2 6882
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 4034
6 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 4006
  Complete submission text file 0001193125-11-141021.txt   728239
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 11845062
SIC: 2834 Pharmaceutical Preparations